title: Investigational drug combined with chemotherapy improves response in patients with BRCA-mutant breast cancer.
authors.forename: Carrie
authors.initials: C
authors.lastname: Printz
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D016190:Carboplatin / Q000008:administration & dosage; D015507:Drugs, Investigational / Q000627:therapeutic use*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D009154:Mutation; D017239:Paclitaxel / Q000008:administration & dosage; D000067856:Poly(ADP-ribose) Polymerase Inhibitors / Q000627:therapeutic use*
chemical_list: D001562:Benzimidazoles; D015507:Drugs, Investigational; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; C521013:veliparib; D016190:Carboplatin; D017239:Paclitaxel